The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 08, 2018
Filed:
Jan. 19, 2017
Applicant:
Ave Maria Biotechnology Llc, Seattle, WA (US);
Inventor:
Theresa Deisher, Seattle, WA (US);
Assignee:
AVM Biotechnology LLC, Seattle, WA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 31/00 (2006.01); C12N 5/00 (2006.01); A61K 35/28 (2015.01); A61K 31/573 (2006.01); C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 35/12 (2015.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 31/573 (2013.01); A61K 39/3955 (2013.01); C07K 16/2878 (2013.01); A61K 35/12 (2013.01); A61K 2039/505 (2013.01); C12N 5/0602 (2013.01);
Abstract
The present invention relates to compositions and methods of inhibiting stem cell binding to organs and tissues, including the blocking of stem cell binding to germinal centers present in lymph tissue. Disclosed are compositions and methods for regenerating germinal centers in lymphatic tissue. Included in the compositions are adjuvants, agonists to CD40, CD28 and the IL-21 receptor, and antagonist to CD20.